Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension

• Status: Completed
• Trial end date: 1969-12-31

Summary

The objective of this PMS study was to monitor and assess the safety of Micardis tablets in patients with hypertension over a period of 6 years

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Telmisartan